GB8429087D0
(en)
*
|
1984-11-16 |
1984-12-27 |
Scras |
Thienopyridine derivatives
|
FR2576901B1
(fr)
*
|
1985-01-31 |
1987-03-20 |
Sanofi Sa |
Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
|
FR2596392B1
(fr)
*
|
1986-03-27 |
1988-08-05 |
Sanofi Sa |
Derives de l'acide a-(hydroxy-3 oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenylacetique, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
FR2597102B1
(fr)
*
|
1986-04-14 |
1988-08-26 |
Sanofi Sa |
Derives de l'acide a-(hydroxy-7 tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
|
FR2623810B2
(fr)
*
|
1987-02-17 |
1992-01-24 |
Sanofi Sa |
Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
|
FR2612929B1
(fr)
*
|
1987-02-17 |
1990-02-09 |
Sanofi Sa |
Enantiomere dextrogyre de 1a-(tetrahydro- 4,5,6,7 thieno (3,2-c) pyridyl-5) (chloro-2 phenyl)-acetate de methyle, son procede de preparation et les compositions pharmaceutiques le renfermant
|
JPH0339159A
(ja)
*
|
1989-07-07 |
1991-02-20 |
Toichi Chikuma |
健康用具
|
US5189170A
(en)
*
|
1989-09-29 |
1993-02-23 |
Sanofi |
Process for the preparation of phenylacetic derivatives of thieno-pyridines
|
FR2652575B1
(fr)
*
|
1989-09-29 |
1992-01-24 |
Sanofi Sa |
Procede de preparation d'acides alpha-bromo phenylacetiques.
|
JPH03242154A
(ja)
*
|
1990-02-17 |
1991-10-29 |
Toichi Chikuma |
健康用具
|
FR2664596B1
(fr)
*
|
1990-07-10 |
1994-06-10 |
Sanofi Sa |
Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
|
FR2672801B1
(fr)
*
|
1991-02-14 |
1995-03-03 |
Sanofi Sa |
Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
|
FI101150B
(fi)
*
|
1991-09-09 |
1998-04-30 |
Sankyo Co |
Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
|
NZ334389A
(en)
*
|
1996-08-28 |
2001-05-25 |
Ube Industries |
Cyclic amine derivatives
|
HU225503B1
(en)
|
1997-05-13 |
2007-01-29 |
Sanofi Aventis |
Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
|
HU222283B1
(hu)
|
1997-05-13 |
2003-05-28 |
Sanofi-Synthelabo |
Eljárás tieno[3,2-c]piridin-származékok előállítására
|
HU225504B1
(en)
|
1997-05-13 |
2007-01-29 |
Sanofi Aventis |
Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
|
FR2769313B1
(fr)
|
1997-10-06 |
2000-04-21 |
Sanofi Sa |
Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
|
PT1063230E
(pt)
|
1998-02-27 |
2003-07-31 |
Sankyo Co |
Compostos amino-ciclicos
|
JP4588877B2
(ja)
|
1998-06-17 |
2010-12-01 |
ブリストル−マイヤーズ スクイブ カンパニー |
Adp−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防
|
HU226421B1
(en)
*
|
1998-11-09 |
2008-12-29 |
Sanofi Aventis |
Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
|
KR100768034B1
(ko)
|
1999-03-17 |
2007-10-17 |
다이이찌 세이야꾸 가부시기가이샤 |
의약 조성물
|
ES2311498T3
(es)
*
|
2000-12-25 |
2009-02-16 |
Daiichi Sankyo Company, Limited |
Composiciones medicinales que contienen aspirina.
|
ATE349451T1
(de)
*
|
2001-01-24 |
2007-01-15 |
Cadila Healthcare Ltd |
Verfahren zur herstellung von clopidogrel
|
IN191030B
(fi)
|
2001-01-24 |
2003-09-13 |
Cadila Healthcare Ltd |
|
CA2352520C
(en)
*
|
2001-07-06 |
2007-10-02 |
Brantford Chemicals Inc. |
Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
|
US6495691B1
(en)
|
2001-07-06 |
2002-12-17 |
Brantford Chemicals Inc. |
Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
|
US6767913B2
(en)
|
2001-12-18 |
2004-07-27 |
Teva Pharmaceutical Industries Ltd. |
Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
|
US7074928B2
(en)
|
2002-01-11 |
2006-07-11 |
Teva Pharmaceutical Industries, Ltd. |
Polymorphs of clopidogrel hydrogensulfate
|
HUP0200438A3
(en)
*
|
2002-02-06 |
2003-10-28 |
Egis Gyogyszergyar Nyilvanosan |
Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
|
ITMI20020933A1
(it)
*
|
2002-05-03 |
2003-11-03 |
Danimite Dipharma S P A |
Procedimento per la sintesi di clopidogrel
|
US6800759B2
(en)
*
|
2002-08-02 |
2004-10-05 |
Teva Pharmaceutical Industries Ltd. |
Racemization and enantiomer separation of clopidogrel
|
IL166593A0
(en)
|
2002-08-02 |
2006-01-15 |
|
Racemization and enantiomer separation of clopidogrel
|
AU2003270861A1
(en)
*
|
2002-10-02 |
2004-04-23 |
Bristol-Myers Squibb Company |
Novel combination of a factor xa inhibitor and clopidogrel
|
US6812363B2
(en)
*
|
2002-10-15 |
2004-11-02 |
Usv Limited |
Racemization of optically active 2-substituted phenyl glycine esters
|
ITMI20022228A1
(it)
*
|
2002-10-21 |
2004-04-22 |
Dinamite Dipharma S P A |
Sali di clopidogrel con acidi alchil-solforici.
|
WO2004074215A1
(en)
*
|
2003-02-03 |
2004-09-02 |
Sunil Sadanand Nadkarni |
Process for preparation of clopidogrel, its salts and pharmaceutical compositions
|
DE10305984A1
(de)
*
|
2003-02-13 |
2004-09-02 |
Helm Ag |
Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
|
US7872019B2
(en)
|
2003-03-12 |
2011-01-18 |
Cadila Healthcare Limited |
Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
|
DK1618111T3
(en)
*
|
2003-04-25 |
2015-02-16 |
Cadila Healthcare Ltd |
Salts of clopidogrel and the process for preparing
|
DE10337773A1
(de)
*
|
2003-08-13 |
2005-03-24 |
Krka Tovarna Zdravil, D.D. |
Kristallisation von festen Formen von Clopidogrel-Additionssalzen
|
GB0321256D0
(en)
|
2003-09-11 |
2003-10-08 |
Generics Uk Ltd |
Novel crystalline compounds
|
US8907090B2
(en)
|
2003-11-03 |
2014-12-09 |
Cadila Healthcare Limited |
Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate
|
CA2454015C
(en)
*
|
2003-12-23 |
2009-11-24 |
Brantford Chemicals Inc. |
A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
|
CA2457459A1
(en)
*
|
2004-02-11 |
2005-08-11 |
Brantford Chemicals Inc. |
Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
|
EP1750701A1
(en)
*
|
2004-06-01 |
2007-02-14 |
IVAX Pharmaceuticals s.r.o. |
Amorphous clopidogrel hydrochloride and its antithrombotic use
|
AR050631A1
(es)
*
|
2004-09-09 |
2006-11-08 |
Novartis Ag |
Combinacion de compuestos organicos
|
WO2006034451A2
(en)
*
|
2004-09-21 |
2006-03-30 |
Teva Pharmaceutical Industries Ltd. |
Crystalline clopidogrel hydrobromide and processes for preparation thereof
|
CA2594763A1
(en)
*
|
2005-02-24 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
|
CZ299213B6
(cs)
|
2005-03-08 |
2008-05-21 |
Zentiva, A. S |
Zpusob racemizace R(-) izomeru methylesteru kyseliny (2-chlorfenyl)-6,7-dihydro-thieno[3,2-c]pyridin-5(4H)-octové
|
WO2006130852A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Dr. Reddy's Laboratories Ltd. |
Recovery of clopidogrel bisulfate
|
WO2007032023A2
(en)
|
2005-07-12 |
2007-03-22 |
Rpg Life Sciences Limited |
A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
|
WO2007029080A1
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Preparation of form i of clopidogrel hydrochloride
|
WO2007029096A2
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Novel polymorphic forms of clopidogrel hydrochloride
|
US7994322B2
(en)
|
2005-09-05 |
2011-08-09 |
Cadila Healthcare Limited |
Processes for the preparation of different forms of (S)-(+)-clopidogrel besylate
|
CN100390180C
(zh)
*
|
2005-12-15 |
2008-05-28 |
上海应用技术学院 |
氯吡格雷及其盐的制备方法
|
KR101235117B1
(ko)
*
|
2005-12-26 |
2013-02-20 |
에스케이케미칼주식회사 |
광학분리에 의한 (s)-(+)-클로피도그렐의 제조방법
|
KR100742134B1
(ko)
*
|
2006-02-07 |
2007-07-24 |
경동제약 주식회사 |
결정성S-(+)-메틸-2-(2-클로로페닐)-2-(6,7-디히드로티에노[3,2-c]피리딘-5(4H)-일)아세테이트·캄실레이트를 포함하는약학적 조성물
|
KR101784001B1
(ko)
|
2006-04-04 |
2017-10-23 |
케이지 액퀴지션 엘엘씨 |
항혈소판제와 산 억제제를 포함하는 경구 투여용 약학 조성물
|
JP2009543759A
(ja)
*
|
2006-04-27 |
2009-12-10 |
アイエヌディー−スイフト ラボラトリーズ リミテッド |
クロピドグレル硫酸水素塩の多形相を調製するプロセス
|
ATE496055T1
(de)
*
|
2006-09-04 |
2011-02-15 |
Ranbaxy Lab Ltd |
Verbessertes verfahren zur herstellung von clopidogrel und pharmazeutisch unbedenklichen salzen davon
|
EP1900358A1
(en)
|
2006-09-16 |
2008-03-19 |
Cimex Pharma AG |
Pharmaceutical formulations comprising clopidogrel
|
WO2008060934A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Acusphere, Inc. |
Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
|
EP1980563A1
(en)
|
2007-04-09 |
2008-10-15 |
BATTULA, Srinivasa Reddy |
Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
|
KR20090086903A
(ko)
*
|
2007-04-18 |
2009-08-14 |
테바 파마슈티컬 인더스트리즈 리미티드 |
개선된 클로피도그렐의 제조 방법
|
KR20160033792A
(ko)
|
2007-04-27 |
2016-03-28 |
사이덱스 파마슈티칼스, 인크. |
클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
|
US7985859B2
(en)
*
|
2007-05-30 |
2011-07-26 |
Wockhardt Ltd. |
Processes for the preparation of clopidogrel
|
WO2009080469A1
(en)
*
|
2007-12-24 |
2009-07-02 |
Sandoz Ag |
Process for the preparation of clopidogrel bisulphate form i
|
EP2095815B1
(en)
|
2008-02-26 |
2011-10-26 |
Laboratorios Lesvi, S.L. |
Pharmaceutical formulations containing clopidogrel
|
WO2009123210A1
(ja)
|
2008-04-01 |
2009-10-08 |
アステラス製薬株式会社 |
血管性疾患の予防剤及び/又は治療剤
|
EP2107061A1
(en)
|
2008-04-02 |
2009-10-07 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Process for the preparation of optically enriched clopidogrel
|
US20090264460A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Mamta Mishra |
Clopidogrel pharmaceutical formulations
|
US20130303477A1
(en)
*
|
2008-05-13 |
2013-11-14 |
The Medicines Company |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
|
US8759316B2
(en)
*
|
2008-05-13 |
2014-06-24 |
The Medicines Company |
Maintenance of platelet inhibition during antiplatelet therapy
|
US9427448B2
(en)
|
2009-11-11 |
2016-08-30 |
The Medicines Company |
Methods of treating, reducing the incidence of, and/or preventing ischemic events
|
WO2009140092A1
(en)
|
2008-05-13 |
2009-11-19 |
The Medicines Company |
Maintenance of platelet inhibition during antiplatelet therapy
|
US20120141468A1
(en)
|
2008-05-13 |
2012-06-07 |
Lisa Ruderman Chen |
Maintenance of platelet inhibition during antiplatelet therapy
|
KR100990949B1
(ko)
|
2008-06-09 |
2010-10-29 |
엔자이텍 주식회사 |
클로피도그렐 및 그의 유도체의 제조방법
|
US8299097B2
(en)
*
|
2008-09-12 |
2012-10-30 |
The Brigham And Women's Hospital, Inc. |
Methods for treating inflammatory disorders
|
EP2346879A1
(en)
*
|
2008-10-24 |
2011-07-27 |
Sandoz AG |
A process for the preparation of s-clopidogrel
|
US8563690B2
(en)
*
|
2008-11-03 |
2013-10-22 |
The Board Of Trustees Of The University Of Illinois |
Modulation of platelet aggregation
|
CN101402641B
(zh)
*
|
2008-11-20 |
2011-05-04 |
天津药物研究院 |
含噻吩并吡啶的肟类衍生物、其制备方法和用途
|
EP2990051B1
(en)
|
2009-04-10 |
2016-10-26 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (mmp-1)
|
EP2429291B1
(en)
|
2009-05-13 |
2016-07-06 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
NZ597510A
(en)
|
2009-06-25 |
2012-12-21 |
Tetra Sia |
NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
|
CN101585842B
(zh)
*
|
2009-07-13 |
2011-07-20 |
北京赛科药业有限责任公司 |
氯吡格雷中杂质b的研究及控制方法
|
PL2498731T3
(pl)
|
2009-11-11 |
2020-07-13 |
Chiesi Farmaceutici S.P.A. |
Sposoby leczenia lub zapobiegania zakrzepicy w stencie
|
US10376532B2
(en)
|
2009-11-11 |
2019-08-13 |
Chiesi Farmaceutici, S.P.A. |
Methods of treating, reducing the incidence of, and/or preventing ischemic events
|
WO2011101865A2
(en)
|
2010-02-19 |
2011-08-25 |
Cadila Healthcare Limited |
Stable pharmaceutical compositions of clopidogrel for parenteral delivery
|
CN102212069A
(zh)
*
|
2010-04-06 |
2011-10-12 |
刘桂坤 |
环烷衍生物及其制备方法和在心脑血管病药物上的应用
|
CN101812071A
(zh)
*
|
2010-05-10 |
2010-08-25 |
杭州和素化学技术有限公司 |
硫酸氢氯吡格雷中间体拆分后的母液处理方法
|
CN102241690B
(zh)
|
2010-05-13 |
2015-08-12 |
天津药物研究院 |
一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途
|
CN101863901B
(zh)
*
|
2010-06-29 |
2012-12-05 |
天津药物研究院 |
2-(取代苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)-N-取代-乙酰胺、其制备方法和用途
|
WO2012007019A1
(en)
|
2010-07-13 |
2012-01-19 |
Pharmathen S.A. |
Process for the preparation of clopidogrel and salts thereof
|
RU2611662C2
(ru)
|
2010-08-26 |
2017-02-28 |
Ипка Лэборэториз Лимитед |
Способы лечения или профилактики тромбообразования или эмболии
|
CN101974015B
(zh)
*
|
2010-10-11 |
2012-05-09 |
天津药物研究院 |
酯类化合物、其制备方法和用途
|
CN101962388B
(zh)
*
|
2010-10-14 |
2012-12-19 |
天津药物研究院 |
乙酰胺衍生物及其制备方法和用途
|
CN101974016A
(zh)
*
|
2010-10-14 |
2011-02-16 |
天津药物研究院 |
酰胺类化合物及其制备方法和用途
|
LT2629776T
(lt)
*
|
2010-10-18 |
2017-11-10 |
Cerenis Therapeutics Holding Sa |
Junginiai, kompozicijos ir būdai, tinkami cholesterolio mobilizavimui
|
WO2012123958A1
(en)
|
2011-02-14 |
2012-09-20 |
Cadila Healthcare Limited |
Highly pure salts of clopidogrel free of genotoxic impurities
|
KR20140047082A
(ko)
|
2011-06-27 |
2014-04-21 |
아이피시에이 래버러토리즈 리미티드 |
항-혈전 화합물
|
WO2013033178A1
(en)
|
2011-08-30 |
2013-03-07 |
University Of Utah Research Foundation |
Methods and compositions for treating nephrogenic diabetes insipidus
|
KR20140101391A
(ko)
|
2011-12-09 |
2014-08-19 |
욱크하르트 리미티드 |
심혈관 질환의 치료 방법
|
CN103665042B
(zh)
*
|
2012-09-21 |
2016-03-16 |
北京普禄德医药科技有限公司 |
光学活性的2-羟基四氢噻吩并吡啶衍生物及其制备方法和用途
|
CN102993210A
(zh)
*
|
2012-12-19 |
2013-03-27 |
苏春华 |
一种吡啶并噻吩的新化合物
|
WO2014118802A1
(en)
|
2013-01-31 |
2014-08-07 |
Pharmazell Gmbh |
An improved process for the preparation of clopidogrel bisulfate form-i
|
CN104447867B
(zh)
*
|
2013-09-17 |
2017-12-26 |
江苏天士力帝益药业有限公司 |
一种噻吩并哌啶衍生物、制备方法及其应用
|
DE102014108210A1
(de)
|
2014-06-11 |
2015-12-17 |
Dietrich Gulba |
Rodentizid
|
HUP1400294A2
(hu)
|
2014-06-13 |
2015-12-28 |
Skillpharm Kft |
Clopidogrel új alkalmazása
|
CN107698620A
(zh)
|
2015-06-23 |
2018-02-16 |
江苏天士力帝益药业有限公司 |
一种氘代噻吩并哌啶衍生物、制备方法及其应用
|
US11260071B2
(en)
|
2017-06-23 |
2022-03-01 |
Chiesi Farmaceutici S.P.A. |
Method of preventing of systemic-to-pulmonary-artery shunt thrombosis
|
EP4070658A1
(de)
|
2021-04-06 |
2022-10-12 |
BIORoxx GmbH |
Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
|
WO2023012479A1
(en)
|
2021-08-03 |
2023-02-09 |
Liqmeds Worldwide Limited |
An oral pharmaceutical solution of clopidogrel
|
CN115260086A
(zh)
*
|
2022-09-28 |
2022-11-01 |
吉林大学 |
一种氟代内标物及其应用和制备方法
|